Views and analysis

COVID heralds a faster future for drug development (if stakeholders can collaborate)

https://pharmaphorum.com/views-and-analysis/covid-heralds-a-faster-future-for-drug-development-if-stakeholders-can-work-together/

Jan van de Winkel: Building Europe’s biotech powerhouse at Genmab

https://pharmaphorum.com/views-and-analysis/jan-van-de-winkel-building-europes-biotech-powerhouse-at-genmab/

Is disability the last bastion of the representation debate?

https://pharmaphorum.com/views-and-analysis/is-disability-the-last-bastion-of-the-representation-debate/

What Is The Best Way to Incentivise a Digital-First Sales Team?

https://pharmaphorum.com/views-and-analysis/what-is-the-best-way-to-incentivise-a-digital-first-sales-team/

Country focus: Hungary carves out a niche in digital pharma

https://pharmaphorum.com/digital/country-focus-hungary-carves-out-a-niche-in-digital-pharma/

GSK on COVID and vaccine development: the pharmaphorum podcast

https://pharmaphorum.com/podcast/gsk-covid-vaccines

Scientific evidence ‘on demand’? Proceedings from an expert roundtable

https://pharmaphorum.com/views-analysis-sales-marketing/scientific-evidence-on-demand-proceedings-from-an-expert-roundtable/

Alexion’s Camilla Harder Hartvig on making the impossible possible in rare disease

https://pharmaphorum.com/views-and-analysis/alexions-camilla-harder-hartvig-on-rare-diseases/

Transformational therapies demand a new mindset

https://pharmaphorum.com/views-and-analysis/transformational-therapies-demand-a-new-mindset/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search